Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.98
-0.27 (-4.28%)
Jun 1, 2026, 3:37 PM EDT - Market open
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $578.55 million as of June 1, 2026. Its market cap has increased by 6.81% in one year.
Market Cap
578.55M
Enterprise Value
700.30M
1-Year Change
6.81%
Ranking
Category
Stock Price
$5.98
Market Cap Chart
Since the IPO on June 3, 2014, Valneva SE's market cap has increased from $450.94M to $578.55M, an increase of 28.30%. That is a compound annual growth rate of 2.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 578.55M | -23.29% |
| Dec 31, 2025 | 754.16M | 107.47% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 239.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 608.14M |
| Altimmune | 593.15M |
| Tectonic Therapeutic | 589.66M |
| Eikon Therapeutics | 586.86M |
| Arvinas | 579.40M |
| Rigel Pharmaceuticals | 564.13M |
| First Tracks Biotherapeutics | 556.88M |
| AgomAb Therapeutics NV | 554.04M |